Novo Nordisk, Inc., is the US affiliate of Novo Nordisk A/S. With global headquarters in Denmark, we are the world’s leading diabetes care company. We discover and develop innovative medicines and make them access to patient throughout the world. Nearly a century of innovation and leadership has led to the development of a comprehensive portfolio of products and delivery systems for diabetes care and other serious chronic conditions.
Our US headquarters are located in Plainsboro, NJ, with a business presence stretching from coast to coast. Visit our quick links below to learn more about Novo Nordisk in the US.